Type 2 cytokines IL-4 and IL-5 reduce severe outcomes from Clostridiodes difficile infection
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 18 references indexed in Scilit:
- Immune Profiling To Predict Outcome of Clostridioides difficile InfectionmBio, 2020
- IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infectionNature Communications, 2019
- Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile InfectionJAMA Surgery, 2018
- Clostridium difficile colitis: pathogenesis and host defenceNature Reviews Microbiology, 2016
- The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophiliaNature Microbiology, 2016
- Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile InfectionCell Reports, 2016
- Markers of Intestinal Inflammation, Not Bacterial Burden, Correlate With Clinical Outcomes in Clostridium difficile InfectionClinical Infectious Diseases, 2013
- Critical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile ColitisInfection and Immunity, 2012
- Evolution of Th2 Immunity: A Rapid Repair Response to Tissue Destructive PathogensPLOS Pathogens, 2011
- Mapping immune response profiles: The emerging scenario from helminth immunologyEuropean Journal of Immunology, 2007